Infuse bone graft is used to stimulate bone growth in spinal fusion operations

Infuse was approved by the Food and Drug Administration (FDA) in 2002 for only one very specific type of spinal surgery – an anterior approach lumbar fusion of one level of the spine between the L5 and S1 vertebrae.

Although, some surgeons have used Infuse for “off-label” procedures, (procedures never approved by the FDA) which can be harmful to patients.

Many patients who received Infuse in “off-label” spinal procedures were not informed and were not told of potential risks of serious and permanent injuries associated with “off-label” use of Infuse.

Patients who received Infuse in “off-label” procedures have suffered:   Sterility, retrograde ejaculation, uncontrolled bone growth at or near the site of the surgery, ongoing or chronic radiating pain in the legs or arms, uro-genital injuries in male patients, and acute severe neck swelling – in cervical spine surgeries – resulting in permanent injury or death.

Medtronic Inc., the nations largest manufacturer of medical devices manufactured Infuse and therefore is responsible for full disclosure to physicians and patients of any risks associated with the use of Infuse.

It is alleged that Medtronic has either fraudulently or negligently misrepresented the benefits and risks of infuse.  It is also alleged that Medtronic improperly and illegally promoted and marketed Infuse for “off-label” uses.

If you feel you are the victim of “off-label” use of Infuse, The Maher Law Firm and Frank Eidson Attorney At Law can help.  We represent you, not the insurance companies.  Contact us today to discuss your potential Infuse Lawsuit with an experienced attorney.